Neurofibroma Clinical Trial
Official title:
Non-interventional Study of Patients With Plexiform Neurofibromas and Neurofibromatosis Type I Starting Selumetinib in Russia
The purpose of this study is to evaluate the effectiveness, safety of selumetinib and patient's parameters of symptomatic inoperable PN NF1 in real clinical practice in Russia
This study will be non-interventional retrospective and prospective study. Assessment of parameters will be carried out as if a patient is treated in real-life clinical setting. The patients should be enrolled into this project after evaluation of eligibility criteria by an investigator 10 clinical sites. No additional procedures besides those already used in the routine clinical practice will be applied to the patients. Study population will consist of pediatric patients aged 3 years and older with NF1 and symptomatic inoperable PN who were prescribed with selumetinib ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01347307 -
Stereotactic Body Radiotherapy for Spine Tumors
|
N/A | |
| Completed |
NCT00314119 -
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
|
||
| Withdrawn |
NCT01567787 -
Proton Radiation Therapy for Spinal Tumors
|
N/A | |
| Terminated |
NCT00716469 -
Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas
|
Phase 1 | |
| Active, not recruiting |
NCT03820778 -
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
|
N/A | |
| Active, not recruiting |
NCT00924196 -
Natural History Study of Patients With Neurofibromatosis Type I
|
||
| Recruiting |
NCT05199376 -
Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1
|
N/A | |
| Completed |
NCT01031901 -
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
|
Phase 1 |